NanoVibronix Research Development vs Income Tax Expense Analysis

NAOV Stock

USD 0.44 0.03 6.38%

NanoVibronix financial indicator trend analysis is infinitely more than just investigating NanoVibronix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NanoVibronix is a good investment. Please check the relationship between NanoVibronix Research Development and its Income Tax Expense accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.

Research Development vs Income Tax Expense

Research Development vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NanoVibronix Research Development account and Income Tax Expense. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between NanoVibronix's Research Development and Income Tax Expense is -0.15. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of NanoVibronix, assuming nothing else is changed. The correlation between historical values of NanoVibronix's Research Development and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of NanoVibronix are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Research Development i.e., NanoVibronix's Research Development and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

-0.15

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Income Tax Expense

Most indicators from NanoVibronix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NanoVibronix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.At this time, NanoVibronix's Tax Provision is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 0.35 in 2025, whereas Issuance Of Capital Stock is likely to drop slightly above 5 M in 2025.

	2022	2023	2024	2025 (projected)
Gross Profit	167K	1.5M	1.8M	1.9M
Total Revenue	752K	2.3M	2.6M	2.8M

Gross Profit Total Revenue

NanoVibronix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Inventory	Other Liab	Current Deferred Revenue
Total Assets		-0.56	0.92	0.29	0.89	0.28	-0.85	-0.87	0.47	0.87	-0.2	-0.28	0.87	0.73	-0.51	0.82	-0.31	0.46	0.89	0.08	0.17	1.0	-0.23	0.64	-0.03	-0.12
Short Long Term Debt Total	-0.56		-0.42	0.5	-0.77	0.0	0.79	0.6	-0.47	-0.51	0.58	0.58	-0.51	-0.41	-0.03	-0.46	0.07	-0.32	-0.6	0.54	0.04	-0.58	0.73	-0.35	-0.13	-0.43
Other Current Liab	0.92	-0.42		0.47	0.71	0.26	-0.64	-0.88	0.44	0.66	-0.12	-0.19	0.66	0.79	-0.62	0.89	-0.28	0.47	0.9	0.27	0.16	0.91	-0.1	0.8	0.03	-0.22
Total Current Liabilities	0.29	0.5	0.47		-0.11	0.15	0.1	-0.28	0.18	0.17	0.68	0.62	0.17	0.23	-0.36	0.28	-0.26	0.2	0.23	0.81	0.06	0.26	0.66	0.27	0.04	-0.32
Total Stockholder Equity	0.89	-0.77	0.71	-0.11		0.21	-0.88	-0.83	0.46	0.78	-0.44	-0.49	0.78	0.7	-0.28	0.76	-0.43	0.33	0.86	-0.38	0.2	0.9	-0.51	0.59	-0.25	-0.04
Property Plant And Equipment Net	0.28	0.0	0.26	0.15	0.21		-0.22	-0.27	-0.38	0.31	-0.06	-0.26	0.31	-0.11	-0.55	0.19	0.01	0.65	0.18	0.16	0.91	0.28	-0.06	0.09	-0.09	-0.46
Net Debt	-0.85	0.79	-0.64	0.1	-0.88	-0.22		0.7	-0.49	-0.93	0.33	0.4	-0.93	-0.43	0.23	-0.51	0.07	-0.5	-0.67	0.14	-0.06	-0.86	0.46	-0.27	-0.18	-0.25
Retained Earnings	-0.87	0.6	-0.88	-0.28	-0.83	-0.27	0.7		-0.54	-0.64	0.19	0.25	-0.64	-0.8	0.38	-0.9	0.52	-0.46	-0.97	0.05	-0.26	-0.87	0.22	-0.78	0.18	0.13
Accounts Payable	0.47	-0.47	0.44	0.18	0.46	-0.38	-0.49	-0.54		0.43	0.16	0.22	0.43	0.43	0.35	0.34	-0.33	0.15	0.52	-0.05	-0.46	0.46	0.04	0.28	0.05	0.52
Cash	0.87	-0.51	0.66	0.17	0.78	0.31	-0.93	-0.64	0.43		-0.13	-0.23	1.0	0.39	-0.35	0.46	-0.07	0.5	0.6	0.12	0.09	0.87	-0.21	0.2	0.16	0.08
Non Current Assets Total	-0.2	0.58	-0.12	0.68	-0.44	-0.06	0.33	0.19	0.16	-0.13		0.98	-0.13	-0.28	0.24	-0.27	-0.21	-0.04	-0.25	0.57	-0.06	-0.23	0.67	-0.28	0.07	0.09
Non Currrent Assets Other	-0.28	0.58	-0.19	0.62	-0.49	-0.26	0.4	0.25	0.22	-0.23	0.98		-0.23	-0.27	0.35	-0.31	-0.22	-0.19	-0.29	0.5	-0.23	-0.31	0.66	-0.29	0.05	0.17
Cash And Short Term Investments	0.87	-0.51	0.66	0.17	0.78	0.31	-0.93	-0.64	0.43	1.0	-0.13	-0.23		0.39	-0.35	0.46	-0.07	0.5	0.6	0.12	0.09	0.87	-0.21	0.2	0.16	0.08
Net Receivables	0.73	-0.41	0.79	0.23	0.7	-0.11	-0.43	-0.8	0.43	0.39	-0.28	-0.27	0.39		-0.42	0.93	-0.55	-0.05	0.89	-0.13	0.0	0.73	-0.17	0.88	-0.35	-0.34
Common Stock Total Equity	-0.51	-0.03	-0.62	-0.36	-0.28	-0.55	0.23	0.38	0.35	-0.35	0.24	0.35	-0.35	-0.42		-0.56	-0.11	-0.22	-0.4	-0.4	-0.47	-0.51	0.08	-0.51	-0.05	0.69
Common Stock Shares Outstanding	0.82	-0.46	0.89	0.28	0.76	0.19	-0.51	-0.9	0.34	0.46	-0.27	-0.31	0.46	0.93	-0.56		-0.54	0.19	0.96	-0.07	0.28	0.82	-0.2	0.94	-0.31	-0.4
Non Current Liabilities Total	-0.31	0.07	-0.28	-0.26	-0.43	0.01	0.07	0.52	-0.33	-0.07	-0.21	-0.22	-0.07	-0.55	-0.11	-0.54		0.13	-0.53	0.34	-0.24	-0.3	-0.02	-0.51	0.81	0.32
Other Current Assets	0.46	-0.32	0.47	0.2	0.33	0.65	-0.5	-0.46	0.15	0.5	-0.04	-0.19	0.5	-0.05	-0.22	0.19	0.13		0.35	0.28	0.37	0.46	-0.13	0.11	0.31	0.16
Other Stockholder Equity	0.89	-0.6	0.9	0.23	0.86	0.18	-0.67	-0.97	0.52	0.6	-0.25	-0.29	0.6	0.89	-0.4	0.96	-0.53	0.35		-0.11	0.21	0.89	-0.25	0.85	-0.23	-0.18
Total Liab	0.08	0.54	0.27	0.81	-0.38	0.16	0.14	0.05	-0.05	0.12	0.57	0.5	0.12	-0.13	-0.4	-0.07	0.34	0.28	-0.11		-0.07	0.06	0.65	-0.07	0.52	-0.11
Property Plant And Equipment Gross	0.17	0.04	0.16	0.06	0.2	0.91	-0.06	-0.26	-0.46	0.09	-0.06	-0.23	0.09	0.0	-0.47	0.28	-0.24	0.37	0.21	-0.07		0.17	-0.05	0.21	-0.38	-0.61
Total Current Assets	1.0	-0.58	0.91	0.26	0.9	0.28	-0.86	-0.87	0.46	0.87	-0.23	-0.31	0.87	0.73	-0.51	0.82	-0.3	0.46	0.89	0.06	0.17		-0.25	0.65	-0.03	-0.13
Common Stock	-0.23	0.73	-0.1	0.66	-0.51	-0.06	0.46	0.22	0.04	-0.21	0.67	0.66	-0.21	-0.17	0.08	-0.2	-0.02	-0.13	-0.25	0.65	-0.05	-0.25		-0.17	0.05	-0.14
Inventory	0.64	-0.35	0.8	0.27	0.59	0.09	-0.27	-0.78	0.28	0.2	-0.28	-0.29	0.2	0.88	-0.51	0.94	-0.51	0.11	0.85	-0.07	0.21	0.65	-0.17		-0.34	-0.42
Other Liab	-0.03	-0.13	0.03	0.04	-0.25	-0.09	-0.18	0.18	0.05	0.16	0.07	0.05	0.16	-0.35	-0.05	-0.31	0.81	0.31	-0.23	0.52	-0.38	-0.03	0.05	-0.34		0.59
Current Deferred Revenue	-0.12	-0.43	-0.22	-0.32	-0.04	-0.46	-0.25	0.13	0.52	0.08	0.09	0.17	0.08	-0.34	0.69	-0.4	0.32	0.16	-0.18	-0.11	-0.61	-0.13	-0.14	-0.42	0.59

Click cells to compare fundamentals

NanoVibronix Account Relationship Matchups

NanoVibronix fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	8.2M	8.6M	5.9M	6.7M	7.7M	8.1M
Other Current Liab	2.5M	1.7M	2.1M	2.3M	2.6M	2.7M
Total Current Liabilities	2.9M	1.9M	2.3M	2.5M	2.8M	1.8M
Total Stockholder Equity	2.4M	6.3M	3.2M	4.0M	4.6M	4.8M
Property Plant And Equipment Net	35K	54K	88K	12K	13.8K	13.1K
Net Debt	(7.1M)	(7.7M)	(2.6M)	(3.3M)	(3.0M)	(2.8M)
Retained Earnings	(42.7M)	(56.9M)	(62.4M)	(66.1M)	(59.5M)	(56.5M)
Accounts Payable	144K	87K	66K	138K	158.7K	103.5K
Cash	7.1M	7.7M	2.7M	3.3M	3.8M	2.6M
Non Current Assets Total	259K	280K	270K	187K	168.3K	228.2K
Non Currrent Assets Other	200K	207K	179K	175K	157.5K	205.1K
Cash And Short Term Investments	7.1M	7.7M	2.7M	3.3M	3.8M	2.6M
Net Receivables	93K	264K	109K	425K	488.8K	513.2K
Common Stock Shares Outstanding	514.9K	1.3M	1.4M	1.8M	2.0M	2.1M
Liabilities And Stockholders Equity	8.2M	8.6M	5.9M	6.7M	7.7M	8.1M
Non Current Liabilities Total	2.9M	406K	330K	232K	208.8K	198.4K
Other Current Assets	590K	166K	612K	47K	54.1K	51.3K
Other Stockholder Equity	45.0M	63.2M	65.6M	70.1M	80.7M	84.7M
Total Liab	5.8M	2.3M	2.6M	2.7M	2.4M	2.2M
Property Plant And Equipment Gross	4.0	54K	88K	12K	13.8K	24.9K
Total Current Assets	8.0M	8.3M	5.6M	6.5M	7.5M	7.8M
Accumulated Other Comprehensive Income	66K	60K	(18K)	(67K)	(77.1K)	(80.9K)
Inventory	145K	175K	2.2M	2.7M	3.1M	3.3M
Other Liab	279K	2.9M	406K	330K	297K	282.2K
Other Assets	194K	255.0	208K	179K	161.1K	216.3K
Net Tangible Assets	1.3M	2.4M	6.3M	3.2M	3.7M	3.9M
Net Invested Capital	2.4M	6.3M	3.2M	4.0M	4.6M	3.4M
Net Working Capital	5.1M	6.4M	3.3M	4.0M	4.6M	3.9M
Capital Stock	9K	24K	28K	2K	1.8K	1.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for NanoVibronix Stock Analysis

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC